Worldwide and China Vitamin H Industry Research Report, 2013

2013-01-23
Published : Jan-2013

This is a professional and depth research report on Global and China Vitamin H (Food Grade Feed Grade Pharmaceutical Grade) Industry. Firstly the report describes the background knowledge of Vitamin H, including Vitamin H ((Food Grade Feed Grade Pharmaceutical Grade) Concepts Classification production process technical parameters; then statistics Global and China Key Manufacturers Vitamin H product 2009-2015 Capacity production cost price production value Gross margins and other relevant data, statistics these enterprises Vitamin H products, customers, raw materials, company background information, then summary statistics and analysis the relevant data of these enterprises. and get Global and China Vitamin H 2009-2015 production market share, different Type Vitamin H production market share, Global and China Vitamin H demand supply and shortage, Global and China Vitamin H 2009-2015 production price cost Gross production value gross margins, etc. At the same time, the report analyzed and discussed supply and demand changes in Vitamin H market and business development strategies, conduct a comprehensive analysis on Global and China Vitamin H industry trends. Finally, the report also introduced 30Ton/year Vitamin H project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and China Vitamin H industry. And thanks to the support and assistance from Vitamin H industry chain related experts and enterprises during Research Team survey and interviews.

Buy a copy of this report @ http://www.reportsnreports.com/reports/215854-2013-deep-research-report-on-global-and-china-vitamin-h-industry.html

Table of Contents

Chapter One Pharmaceutical Grade Vitamin H Industry Overview    1
1.1 Pharmaceutical Grade Vitamin H Definition    1
1.2 Pharmaceutical Grade Vitamin H Product Specification    1
1.3 Pharmaceutical Grade Vitamin H Price Analysis    2
1.4 Pharmaceutical Grade Vitamin H Manufacturing Process    2
1.5 Pharmaceutical Grade Vitamin H Cost Structure    5
1.6 Pharmaceutical Grade Vitamin H Industry Overview    6

Chapter Two Feed Grade Vitamin H Industry Overview    6
2.1 Feed Grade Vitamin H Definition    6
2.2 Feed Grade Vitamin H Product Specification    7
2.3 Feed Grade Vitamin H Price Analysis    7
2.4 Vitamin H Manufacturing Process    7
2.5 Feed Grade Vitamin H Cost Structure    8
2.6 Feed Grade Vitamin H Industry Overview    9

Chapter Three Food Grade Vitamin H Industry Overview    9
3.1 Food Grade Vitamin H Definition    10
3.2 Food Grade Vitamin H Product Specification    10
3.3 Food Grade Vitamin H Price Analysis    10
3.4 Food Grade Vitamin H Manufacturing Process    11
3.5 Vitamin H Cost Structure    12
3.6 Food Grade Vitamin H Industry Overview    13

Chapter Four Vitamin H Industry Chain Analysis    13
4.1 Naphthenic Acid Market Analysis    13
4.2 Feed Industry Market Analysis    13
4.3 Naphthenic Acid -Vitamin H –Feed Industry Chain Analysis    14

Chapter Five Vitamin H Production Supply Sales Demand Market Status and Forecast    15
5.1 Global and China Vitamin H Capacity Production Overview    15
5.2 Global and China Key Manufacturers Vitamin H Capacity Utilization Rate    27
5.3 Global and China Vitamin H Demand Overview    28
5.4 Global and China Vitamin H Supply Demand Shortage    30
5.5 Global and China Vitamin H Cost Price Production Value Gross Margin    32
5.6 China Vitamin H Import Export Consumption    34

Chapter Six Vitamin H Key Manufacturers Research    35
6.1 S.D Pharmaceutical    35
6.2 Zhejiang Medicine    41
6.3 NHU    48
6.4 Hegno    54
6.5 Kexing Biochem    59

Chapter Seven Vitamin H New Project Investment Feasibility Analysis    65
7.1 Vitamin H New Project SWOT Analysis    65
7.2 30Ton/year Vitamin H New Project Investment Feasibility Analysis    66

Chapter Eight Vitamin H Industry Research Conclusions    66

Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215854

Contact sales@reportsandreports.com for more details.

 

 

Filed in: Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

EpiCast Report: Alzheimer’s Disease – Epidemiology Forecast to 2026

EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2026 Summary Alzheimer's disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized by the death of brain cells, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity (NIA, 2017). AD is the most common cause of dementia in people age 60 years and older, and accounts for approximately 75% of the total dementia cases worldwide. To forecast the total prevalent cases of AD in adults ages 60 years and older in the 7MM during the forecast period (2016-2026), our epidemiologists identified country-specific population-based studies that used the diagnostic criteria based on the Diagnostic and Sta......
$3995

EpiCast Report: Epilepsy – Epidemiology Forecast to 2026

EpiCast Report: Epilepsy - Epidemiology Forecast to 2026 Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain (WHO, 2017). It is one of the most common neurological conditions globally (WHO, 2017). Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered a seizure and is referred to a specialist, where a description of the symptoms before the seizure and the seizure itself are used for a diagnosis (NHS, 2014). In the 7MM, the lifetime diagnosed prevalent cases of epilepsy will increase from almost 11 million cases in 2016 to just over 11.5 million cases in 2026, at an Annual Growth Rate (AGR) of almost 0.5% pe......
$3995

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report p......
$1000

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Argentina

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina Summary Pharmaceutical market increased from over US$3 Billion in 2009 to around US$6.5 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of nearly 10%. It is expected to cross US$10 Billion in 2021 at a CAGR of about 10%. In 2009, the medical device market was valued at just over US$1 Billion. It grew at a CAGR of 4% between 2009 and 2016 and reached around US$1.3 Billion. It is expected to grow at a CAGR of about 5%, from around US$1.4 Billion in 2017 to over US$1.7 Billion in 2021. Argentina is the third-largest pharmaceutical market in Latin America after Brazil and Mexico. With a relatively low-cost base and high-quality professionals in the biotechnology sector, Argentina is home to over 130 ......
$1995

EpiCast Report: Melanoma – Epidemiology Forecast to 2026

EpiCast Report: Melanoma - Epidemiology Forecast to 2026 Summary Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of skin (WHO, 2014). Melanocytes are embryological derivatives of neural crest tissue, and as such, any region of the body that is a derivative of the neural crest and contains melanocytes-namely areas of skin, meninges, mucous membranes, esophagus, and eyes-can develop melanoma (Komarnicky-Kocher and Alite, 2013). In the 7MM, our epidemiologists forecast the diagnosed incident cases of melanoma to increase to over 200,000 cases by 2026, at an Annual Growth Rate (AGR) of almost 2.5%. The US will have the highest number of melanoma cases throughout the forecast period. The five-year diagn......
$3995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela Summary Venezuela ranked 187 out of 190 countries in ease of doing business. In July 2017, rating firm Standard & Poor's downgraded Venezuela's economy to CCC with a negative outlook. Moody's also downgraded its rating to Caa3 with a negative outlook, while Fitch rated it at CCC with a negative outlook. Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. The value of the market was US$12.6 Billion in 2015, having increased from US$5.7 Billion in 2009, at a Compound Annual Growth Rate (CAGR) of 14.1%. Drug prices in Venezuela are ......
$1995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Russia

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Russia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2016, Russia population was approxi......
$1995

ForeSights: Salt Therapy – An old-fashioned, non-invasive treatment enjoying a renaissance as a new health and wellness solution

ForeSights: Salt Therapy - An old-fashioned, non-invasive treatment enjoying a renaissance as a new health and wellness solution Summary Salt therapy is a non-invasive treatment that uses aerated salt or a salt bath to deliver health and wellness benefits. It comes in two forms: dry salt therapy (halotherapy) and wet salt therapy (flotation therapy). Both forms of salt therapy are claimed to promote relaxation and rejuvenation. Salt therapy is an old-fashioned, drug-free treatment leveraging the claimed natural antibacterial and anti-inflammatory properties of salt that capitalizes on growing interest in complementary and alternative medicine. Scope - Dry salt therapy (halotherapy) takes mineral-rich salt and grinds it into a fine powder that is dispensed into the air to cre......
$495

EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2026

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026 Summary Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining. To forecast the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA in the 7MM, GlobalData epidemiologists selected nationally representative,......
$3995

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on Hematopoietic Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Repo......
$2500